Biota Scientific Management Pty Ltd

Aviragen Therapeutics, Inc.

Silas Bond

Alistair George Draffan

Michael Harding

Tyrone Pieter Jeynes

Rosliana Halim

Jeffrey Peter Mitchell

Paula Francom

Vanessa Anne Sanford

Penelope Anne Mayes

John Nicholas Lambert

Barbara Frey

George Kukolj

Richard Bethell

Jianmin Duan

Michael John Lilly

Richard Hufton

Chin Yu Lim

Edward Tyndall

Roland Henry Nearn

Saba Jahangiri

Saba Hangiri

Chin Lim Lim

The present invention relates to polycyclic antiviral compounds, and salts thereof, methods for their preparation and compositions containing them, and the use of the compounds and composition in the treatment of viral infections.

Polycyclic agents for the treatment of respiratory syncytial virus infections

The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections. 

Viral polymerase inhibitors

The invention relates to the use of bicyclic nucleosides and nucleotides based on formula (II) for the treatment of infectious diseases, and in particular, viral infections.

Bicyclic nucleosides and nucleotides as therapeutic agents

Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B&#x2014;C) may be CH&#x2014;CHetc., (R) may be phenyl and substituted forms thereof, (R) may be assorted substituents. 

The present disclosure relates to the use and methods of manufacture of bicyclic nucleosides and nucleotides for the treatment and prevention of infectious and proliferative diseases, including microbial infections and cancer.

Growing community of inventors

Lynbrook, Australia

Silas Bond